Biomarkers in Trypanosoma cruzi-Infected and Uninfected Individuals with Varying Severity of Cardiomyopathy in Santa Cruz, Bolivia

Hyperendemic Chagas Disease and the Unmet Need for Pacemakers in the Bolivian Chaco

(2014) Eva H. Clark et al.   PLoS Neglected Tropical Diseases

Matrix metalloproteinases 2 and 9 as diagnostic markers in the progression to Chagas cardiomyopathy

(2013) Norma Leticia Bautista-López et al.   AMERICAN HEART JOURNAL

Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review

(2013) Ana Requena-Méndez et al.   Expert Review of Anti-Infective Therapy

Angiotensin Type 2 Receptor Stimulation Ameliorates Left Ventricular Fibrosis and Dysfunction via Regulation of Tissue Inhibitor of Matrix Metalloproteinase 1/Matrix Metalloproteinase 9 Axis and Transforming Growth Factor β1 in the Rat Heart

(2013) Dilyara Lauer et al.   HYPERTENSION

Matrix Metalloproteinases 2 and 9 Are Differentially Expressed in Patients with Indeterminate and Cardiac Clinical Forms of Chagas Disease

(2013) Rafaelle Christine Gomes Fares et al.   INFECTION AND IMMUNITY

Serum Proteomic Signature of Human Chagasic Patients for the Identification of Novel Potential Protein Biomarkers of Disease

(2012) Jian-Jun Wen et al.   MOLECULAR & CELLULAR PROTEOMICS

Myocardial Deformation Analysis in Chagas Heart Disease With the Use of Speckle Tracking Echocardiography

(2011) Ana García-Álvarez et al.   JOURNAL OF CARDIAC FAILURE

Antitrypanosomal Therapy for Chronic Chagas' Disease

(2011) Caryn Bern   NEW ENGLAND JOURNAL OF MEDICINE

Hypercoagulability biomarkers in Trypanosoma cruzi-infected patients

(2011) Dolors Tassies et al.   THROMBOSIS AND HAEMOSTASIS

Fibrosis in endstage human heart failure: Severe changes in collagen metabolism and MMP/TIMP profiles

(2010) Victoria Polyakova et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Increased Morbidity in Chagas Cardiomyopathy Patients Compared to Other Nonischemic Cardiomyopathy Patients in US-Based Population

(2010) Mahmoud Traina et al.   JOURNAL OF CARDIAC FAILURE

Identification of Novel Diagnostic Serum Biomarkers for Chagas' Disease in Asymptomatic Subjects by Mass Spectrometric Profiling

(2010) M. Ndao et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Chagas disease

(2010) Anis Rassi et al.   LANCET

Chagas Cardiomyopathy in the Context of the Chronic Disease Transition

(2010) Alicia I. Hidron et al.   PLoS Neglected Tropical Diseases

Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and Brain Natriuretic Peptide in the Early Identification of Cardiac Damage

(2010) Ana Garcia-Alvarez et al.   PLoS Neglected Tropical Diseases

Serum metalloproteinases MMP-2, MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in patients on hemodialysis

(2009) Jacek Rysz et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease

(2009) J Antonio Marin-Neto et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Pivotal role for TGF-β in infectious heart disease: The case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy

(2008) Tania C. Araújo-Jorge et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Biomarkers in Heart Failure

(2008) Eugene Braunwald   NEW ENGLAND JOURNAL OF MEDICINE